With its new listing on the TSX Venture Exchange, Pickering-based NSP Pharma Corp. (TSXV: NSP) is delivering on its promise of dynamic growth as its popular Modèle line of anti-aging skincare products make it a leader in the growing North American cosmeceutical market.   ;   « We’re a new Canadian company selling 16 product SKUs in more than 9,100 pharmacies across North America, a strong portfolio that rivals even the biggest names in the industry, » said Sergio Martines, President and CEO of NSP Pharma.   ;   « Listing on the TSX Venture Exchange better positions NSP Pharma to attract the marketing capital it needs to continue building Modèle into a global cosmeceutical market leader, » he adds.   ;   Cosmeceuticals are cosmetics with pharmaceutical properties. Cosmeceutical sales are driven by wrinkle-conscious baby boomers who are looking for safe and effective alternatives to needles and old-style creams to reduce the visible effects of aging. Boomer women in particular are looking for premium-quality skin care products, and are responding to cosmeceutical product promises, attractive packaging and visible results.   ;   According to Cleveland-based market research firm The Freedonia Group, demand for anti-aging products is expected to increase 11.1 per cent per

Ce contenu est restreint aux membres. Si vous êtes un utilisateur enregistré, connectez vous. Les nouveaux utilisateurs peuvent s'enregistrer ci-dessous.

Connexion pour les Utilisateurs enregistrés
   
Nouvel Utilisateur?
*Champ requis